Sema3A(aa363-377) -kLytic

General Information


DRACP ID  DRACP01384

Peptide Name   Sema3A(aa363-377) -kLytic

Sequence  NYQWVPYQGRVPYPRGGGKLLLKLLKKLLKlLKKK

Sequence Length  35

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
BXPC-3 Pancreatic ductal adenocarcinoma Carcinoma IC50=5.7±2.3μM WST-8 assay 48h Patent
CFPAC-1 Cystic fibrosis; Pancreatic ductal adenocarcinoma; Cystic fibrosis Carcinoma IC50=6.7±0.1μM WST-8 assay 48h Patent
PANC-1 Pancreatic ductal adenocarcinoma Carcinoma IC50=13±2.7μM WST-8 assay 48h Patent
SU.86.86 Pancreatic adenocarcinoma Carcinoma IC50=5.2±0.4μM WST-8 assay 48h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Pancreatic epithelium: IC50>20μM; MRC-5: IC50>50μM; Human normalhepatocyte cell: IC50=37.5μM

Target  Epidermal growth factor receptor (EGFR)

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  l=D-Leucine; k=D-Lysine

Chiral  Mix



Physicochemical Information


Formula  C193H318N52O40

Absent amino acids  ACDEFHIMST

Common amino acids  KL

Mass  461361

Pl  11.3

Basic residues  10

Acidic residues  0

Hydrophobic residues  11

Net charge  10

Boman Index  -3885

Hydrophobicity  -66

Aliphatic Index  105.71

Half Life 
  /

Extinction Coefficient cystines  9970

Absorbance 280nm  293.24

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 2011/0319336 A1

Patent Title  Selective anticancer chimeric peptide.

Other Iinformation  Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013

Other Published ID  CN102238965A  EP2370107A2  WO2010064207A2  WO2010064207A3 




DRACP is developed by Dr.Zheng's team.